Primary Amyloidosis — Trials

Primary Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04847453	Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis	active not recruiting	Phase 1	24	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT06649695	A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis	active not recruiting	Phase 2	30	European Myeloma Network B.V.NETWORK	6	Jul 20, 2026